COMPARATIVE STUDIES WITH DIFFERENT CYCLODEXTRIN DERIVATIVES IN IMPROVING THE SOLUBILITY AND DISSOLUTION OF SAQUINAVIR

Bharani S Sogali; Vikram Bn; Ramana Murthy Kv

doi:10.22159/ajpcr.2018.v11i6.24836

Authors

Bharani S Sogali Department of Pharmaceutics, Krupanidhi College of Pharmacy, Bengaluru â€“ 560 035, Karnataka, India. http://orcid.org/0000-0001-8200-0300
Vikram Bn Department of Pharmaceutics, Krupanidhi College of Pharmacy, Bengaluru â€“ 560 035, Karnataka, India.
Ramana Murthy Kv Department of Pharmaceutics, Andhra University, Visakhapatnam, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i6.24836

Keywords:

Saquinavir, Cyclodextrin, Complexation, Freeze drying, Sulfobutyl ether beta cyclodextrin

Abstract

Objective: The present study was aimed to perform comparative studies with different cyclodextrin (CD) derivatives and to study the effect of different methods of preparation in improving the solubility and dissolution of saquinavir (SQV).

Methods: Phase solubility studies were performed with beta CD (Î²CD), hydroxypropyl Î²CD, randomly methylated Î²CD, and sulfobutyl ether Î²CD (SBE7Î²CD). Complexes were prepared using physical mixture, coevaporation, kneading, spray drying, and freeze-drying techniques. For complexes prepared by spray drying, process parameters were optimized based on percentage yield. The prepared complexes were characterized using Fourier-transform infrared spectroscopy, differential scanning calorimetry, X-ray diffraction studies, nuclear magnetic resonance spectroscopy, and scanning electron microscopy. In vitro drug release study was conducted in phosphate buffer pH 6.8 and mean dissolution time (MDT) was calculated for all freeze-dried complexes.

Results: Phase solubility studies showed a linear relationship with an increase in CD concentration and phase diagrams were of AL type. Highest stability constant was observed with SQV-SBE7Î²CD (8281.28/M). All characterization studies proved complexation. Among four CD derivatives, SQV complexed with SBE7Î²CD by freeze-drying showed maximum drug release and low MDT of 20.67.

Conclusion: Among different CDs, SBE7Î²CD proved as ideal CD derivative, and among different methods of preparations, freeze-drying method was found to be useful in improving the solubility and dissolution of SQV.

Downloads

Download data is not yet available.

Author Biography

Bharani S Sogali, Department of Pharmaceutics, Krupanidhi College of Pharmacy, Bengaluru â€“ 560 035, Karnataka, India.

Professor, Department of Pharmaceutics,

References

Loftsson T, Brewster ME, Derendorf H, Bodor N. 2-Hydroxypropyl- Î²-cyclodextrin: Properties and usage in pharmaceutical formulations. Pharm Ztg Wiss 1991;4:5-10.

Arora P, Singh J, Chadha R. Physicochemical characterization and evaluation of telmisartan: Hydroxypropyl-Î²-cyclodextrin: Tween 80 inclusion complex. Int J Pharm Pharm Sci 2017;9:51-8.

Gera S, Cheruvu S, Zakkula A, Sampathi S. Synthesis and evaluation of olmesartan medoxomil complex with sbe7 Î²-cd for enhanced dissolution and bioavailability. Int J Pharm Pharm Sci 2016;8:333-43.

Sogali BS, Sushant MS, Murthy KV. Comparative evaluation of cyclodextrins in improving the dissolution of ritonavir. Int J Pharm 2016;6:159-76.

Chowdary KP, Nalluri BN. Nimesulide and beta-cyclodextrin inclusion complexes: Physicochemical characterization and dissolution rate studies. Drug Dev Ind Pharm 2000;26:1217-20.

Palmeiri GF, Angeli DG, Giovannnucci G, Martelli S. Inclusion of methoxytropate in beta- and hydroxyl propyl beta cyclodextins: Comparision of preparation methods. Drug Dev Ind Pharm 1997; 23:27-37.

Palmieri GF, Wehrle P, Stamm A. Inclusion of vitamin D2 in Î²-cyclodextrin: Evaluation of different complexation methods. Drug Dev Ind Pharm 1993;19:875-85.

Nagase Y, Hirata M, Wada K, Arima H, Hirayama F, Irie T, et al. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin. Int J Pharm 2001;229:163-72.

Moyano JR, Arias MJ, Gines JM, Perez JI, Rabasco AM. Dissolution behavior of oxazepam in the presence of cyclodextrins: Evaluation of oxazepam dimeb binary system. Drug Dev Ind Pharm 1997;23:379-85.

Castillo JA, Palomo-Canales J, Garcia JJ, Lastres JL, Bolas F, Torrado JJ, et al. Preparation and characterization of albendazole beta-cyclodextrin complexes. Drug Dev Ind Pharm 1999;25:1241-8.

DÃaz D, Escobar Llanos CM, Bernad Bernad MJ. Study of the binding in an aqueous medium of inclusion complexes of several cyclodextrins involving fenoprofen calcium. Drug Dev Ind Pharm 1999;25:107-10.

Stella VJ, Rajewski R. Derivatives of Cyclodextrins Exhibiting Enhanced Aqueous Solubility and Pharmaceutical use Thereof, United States Patent No. 5. 1992 July 18.

Tam-Zaman N, Tam YK, Tawfik S, Wiltshire H. Factors responsible for the variability of saquinavir absorption: Studies using an instrumented dog model. Pharm Res 2004;21:436-42.

Sinko PJ, Kunta JR, Usansky HH, Perry BA. Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits. J Pharmacol Exp Ther 2004;310:359-66.

U.S. Food and Drug Administration. Invirase. Available from: http:// www.fda.gov/medwatch/SAFETY/2003/03DEC_PI/Invirase_PI.pdf.

Guo X, Shuang S, Wang X, Dan C, Pan J, Enein HY. Comparative study on the inclusion behavior of cyclodextrin derivatives with venoruton and rutin by thin layer chromatography. Biomed Chromatogr 2004;18:559-63.

Arima H, Yunomae K, Miyake K, Irie T, Hirayama F, Uekama K, et al. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. J Pharm Sci 2001;90:690-701.

Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instr 1965;4:117-212.

Hirayama F, Uekama K. Methods of investigating and preparing inclusion compounds. In: Duchene D, editor. Cyclodextrins and their Industrial Uses. Paris: Editions de Sante; 1987. p. 131-72.

Hedges AR. Industrial applications of cyclodextrins. Chem Rev 1998;98:2035-44.

Rajendrakumar K, Madhusudan S, Pralhad T. Cyclodextrin complexes of valdecoxib: Properties and anti-inflammatory activity in rat. Eur J Pharm Biopharm 2005;60:39-46.

Maa YF, Nguyen PA, Andya JD, Dasovich N, Sweeney TD, Shire SJ, et al. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm Res 1998;15:768-75.

Andya JD, Maa YF, Costantino HR, Nguyen PA, Dasovich N, Sweeney TD, et al. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-igE monoclonal antibody. Pharm Res 1999;16:350-8.

Foster TP, Leatherman MW. Powder characteristics of proteins spray-dried from different spray-dryers. Drug Dev Ind Pharm 1995;21:1705- 23.

Maa YF, Costantino HR, Nguyen PA, Hsu CC. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Pharm Dev Technol 1997;2:213-23.

Broadhead J, Rouan SK, Hau I, Rhodes CT. The effect of process and formulation variables on the properties of spray-dried b-galactosidase. J Pharm Pharmacol 1994;46:458-67.

Dunbar CA, Concessio NH, Hickey AJ. Evaluation of atomization performance in production of respirable spray-dried particles. Pharm Dev Tech 1998;3:433-41.

Fukuda M, Miller DA, Peppas NA, McGinity JW. Influence of sulfo butyl ether Î²-cyclodextrin on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion. Int J Pharm 2008;350:188-96.

United States Pharmacopoeia 30-National Formulary 25. Twin Brook Parkway, Rockville. USA: United States Pharmacopoeial Convention Inc.; 2007. p. 3143.

U.S. Food and Drug Administration. Recommended Dissolution Methods. Available from: http://www.accessdata.fda.gov/scripts/cder/ dissolution/index.cfm.

Pathak SM, Musmade P, Dengle S, Karthik A, Bhat K, Udupa N, et al. Enhanced oral absorption of saquinavir with methyl-beta-cyclodextrin-preparation and in vitro and in vivo evaluation. Eur J Pharm Sci 2010;41:440-51.